Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-04-21
DOI
https://doi.org/10.3389/fimmu.2026.1772428
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms

G.B. Blumenschein, Guojun Lang, Yi Sun, Jianguo Wen et al.
Frontiers in Immunology
CAR-T cell therapy research
article

Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms

G.B. Blumenschein, Guojun Lang, Yi Sun, Jianguo Wen, Bowen Ma, Lei He, Hong Ma
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 17
The University of Texas MD Anderson Cancer Center (US), Sanyo (Japan) (JP), Rice Research Institute (CN), Institute of Neuroimmunology of the Slovak Academy of Sciences (SK), The University of Texas Health Science Center (US), Rice University (US), The University of Texas Health Science Center at Houston (US)
Good health and well-being
Openalex Percentile: Top 21%
CAR-T cell therapy research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.